Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Treasury Shares (2024 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed Treasury Shares for 3 consecutive years, with $86000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Treasury Shares rose 26.47% to $86000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $86000.0, a 26.47% increase, with the full-year FY2025 number at $86000.0, up 26.47% from a year prior.
  • Treasury Shares was $86000.0 for Q4 2025 at Ekso Bionics Holdings, down from $100000.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $836000.0 in Q1 2025 to a low of $68000.0 in Q4 2024.